EarningsQ4 2020 Earnings Report

9 Meters Biopharma (NMTRQ) Q4 2020 Earnings Report

1,941 Followers

NMTRQ Q4 2020 EPS Results

Actual EPS-$0.60

Consensus EPS―

Beat/Miss―

One Year Ago EPS-$4.51

Actual Revenue$0.00

Expected Revenue―

Beat/Miss―

YoY Revenue Growth―

QuarterQ4 2020

Date03/22/2021

TimeAfter Close

Conference CallMonday, March 22, 2021

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
May 14, 2024	2024 (Q1)	- / -	-1.02	―
Mar 20, 2024	2023 (Q4)	- / -	―	―
Aug 16, 2023	2023 (Q2)	-1.06 / -1.06	-0.8	-32.50% (-0.26)
May 15, 2023	2023 (Q1)	-0.69 / -1.02	-0.8	-27.50% (-0.22)
Mar 28, 2023	2022 (Q4)	-0.82 / -1.06	-0.8	-32.50% (-0.26)
Nov 08, 2022	2022 (Q3)	-0.75 / -0.72	-1	28.00% (+0.28)
Aug 15, 2022	2022 (Q2)	-0.83 / -0.80	-0.6	-33.33% (-0.20)
Mar 23, 2022	2021 (Q4)	-0.72 / -0.80	-0.6	-33.33% (-0.20)
Nov 15, 2021	2021 (Q3)	-0.80 / -1.00	-1.2	16.67% (+0.20)
Aug 12, 2021	2021 (Q2)	-0.60 / -0.60	-11.4	94.74% (+10.80)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed